Security key
92243G108
Vaxcyte, Inc. - Common Stock, $0.001 par value per share (PCVX)
CUSIP: 92243G108
Q3 2025 13F Holders as of 30 Sep 2025
- Security type / class
- Equity / Common Stock, $0.001 par value per share
- Total 13F shares
- 141,285,706
- Total 13F value
- $5,088,913,432
- Share change
- -6,310,994
- Put/Call ratio
- 28%
- SEC-reported price per share
- $36.02
- Number of holders
- 282
- Value change
- -$216,599,261
- Number of buys
- 134
- Number of sells
- 146
- Shares outstanding
- 145,782,011
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2025
Institutions
282
Top holders
10
PCVX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2025
Previous quarter: Q2 2025
Vaxcyte, Inc. SEC filings
Vaxcyte, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 92243G108
Recent filing periods:
Ownership snapshot
Top reported holders of PCVX - Vaxcyte, Inc. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BlackRock, Inc.
Disclosed value leader
JANUS HENDERSON GROUP PLC
Comparable rows
15/15
Latest evidence
30 Jun 2025
13F
13D/G
Lead comparable stake: 7.6%
13D/G row: BlackRock, Inc.
Showing 1-6 of 15 holder rows.
Quick read
BlackRock, Inc. leads the comparable SEC ownership view at 7.6%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BlackRock, Inc.'s linked filing trail.
Comparable ownership
Top 5
BlackRock, Inc.
7.6%
JANUS HENDERSON GROUP PLC
10%
FMR LLC
8.3%
VANGUARD GROUP INC
8.2%
RA CAPITAL MANAGEMENT, L.P.
8.2%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BlackRock, Inc. |
13F
13D/G
Company
|
7.6%
from 13D/G
|
$345,979,336
10,642,243 shares
|
— | 30 Jun 2025 |
| JANUS HENDERSON GROUP PLC |
13F
Company
|
10%
|
$477,656,211
14,691,344 shares
|
— | 30 Jun 2025 |
| FMR LLC |
13F
Company
|
8.3%
|
$395,030,620
12,151,050 shares
|
— | 30 Jun 2025 |
| VANGUARD GROUP INC |
13F
Company
|
8.2%
|
$390,025,233
11,997,085 shares
|
— | 30 Jun 2025 |
| RA CAPITAL MANAGEMENT, L.P. |
13F
Company
|
8.2%
|
$389,014,367
11,965,991 shares
|
— | 30 Jun 2025 |
| T. Rowe Price Investment Management, Inc. |
13F
Company
|
4.1%
|
$195,097,000
6,001,124 shares
|
— | 30 Jun 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
282
Shares
141,285,706
Rows available
282
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
292
Q3 2025 holders
282
Holder diff
-10
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 value | Q3 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend